🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Immigrants play a huge role in US health care and the hospital workforce. If we discourage them from entering the US, this can make shortages worse—causing understaffing, decreased access to care, poorer quality of care, and more burnout among clinicians already in practice.

New U.S. FDA accelerated approval: Dato-DXd for EGFR+ NSCLC after prior EGFR therapy + platinum chemo. ▫️n=114, TROPIONLung01&05 ▫️ORR: 45% ▫️DoR: 6.5 mo ⚠️ ILD, ocular AEs, stomatitis, embryo-fetal risk OncoAlert #lcsm

🚨New FDA-accelerated approval for EGFRm NSCLC! The FDA granted accelerated approval to Dato-DXd on 6/23/25 for pts with locally advanced/metastatic EGFRm NSCLC who have received prior EGFR-directed therapy and platinum chemo.

Dato-DXd with FDA accelerated approval based on TROPION-Lung05 and Lung01 studies in EGFR+ NSCLC. Great news for patients!

📢 In a new article published by Union for International #CancerControl , Narjust Florez, MD, FASCO discusses the hidden epidemic of lung cancer in women especially never-smokers and the urgent need for gender-responsive, equitable care. 📖 Read: uicc.org/news-and-updat… #LungCancer #FlorezLab

Now JAMA Oncology - commentary on the ACHIEVE study in #EGFR NSCLC and on dose selection for targeted therapy in general. Proud to have worked on this under the direction of Dr. Jennifer A. Marks, MD. jamanetwork.com/journals/jamao…

One page takeaway from #LUMINOSITY study that resulted in Teliso-V FDA Oncology approval for c-met overexpression metastatic NSCLC. #OncTwitter #MedTwitter #lcsm D. Ross Camidge OncoAlert

Nice paper from France on Survival of Patients with Lung Adeno Dx. in 2000, 2010, and 2020 in a public hospitals. Huge impact of TKI and IO on survival! A lot more room to improve but importantly pts need access to these drugs globally!! ⁦#LCSM Chat⁩ evidence.nejm.org/doi/full/10.10…

Rami Manochakian MD, FASCO Cancer Education Eric K. Singhi, MD Stephen V Liu, MD Hossein Borghaei, DO gilberto lopes Benjamin Levy Shenduo Li, MD, PhD Dr. Yanyan Lou Vamsi Velcheti, MD MBA FASCO Maria Antonia Vélez Reema Tawfiq, MD

Clinical Trials 101: Enrolling and Starting Treatment - 2025 Patient Education Ambassadors Program youtu.be/6bCSw48Gwa8?si… via YouTube In this series, Dr. Maria Antonia Vélez begins her overview of clinical trials by discussing how patients begin the process, from enrollment to

Clinical Trials 101: What to Expect in Phase I Trials - 2025 Patient Education Ambassadors Program youtu.be/7sbWSq4zfYk?si… via YouTube In this series, Dr. Maria Antonia Vélez discusses what Phase I clinical trials are, and the pros and cons of participating in one. For more,

Clinical Trials 101: What to Expect in Phase II Trials - 2025 Patient Education Ambassadors Program youtu.be/a9URDAWiRwE?si… via YouTube In this series, Dr. Maria Antonia Vélez covers Phase II clinical trials and what to expect when participating, as well as pros and cons. For

Clinical Trials 101: What to Expect in Phase III Trials- 2025 Patient Education Ambassadors Program youtu.be/d75KlF2qV2E?si… via YouTube In this series, Dr. Maria Antonia Vélez discusses Phase III clinical trials, and what a person can expect when participating in one, as well as the

Clinical Trials 101: Myths and FAQs - 2025 Patient Education Ambassadors Program youtu.be/eYATEQCwi5U?si… via YouTube In this series, Dr. Maria Antonia Vélez discusses common myths regarding clinical trials, and the most common questions asked about participating in them. For more,

Ensayos Clínicos 101: Inicio del Tratamiento - 2025 Patient Education Ambassadors Program youtu.be/Ee3Fs6ZckXc?si… via YouTube En este video, la Dra. Maria Antonia Vélez comienza su descripción general de los ensayos clínicos explicando cómo los pacientes comienzan el proceso, desde

Ensayos Clínicos 101: Ensayos Clínicos de Fase II - 2025 Patient Education Ambassadors Program youtu.be/t_ErpFDjwKs?si… via YouTube En este video, la Dra. Maria Antonia Vélez cubre los ensayos clínicos de fase II y qué esperar al participar, así como los pros y los contras. Para

Ensayos Clínicos 101: Ensayos Clínicos de Fase III - 2025 Patient Education Ambassadors Program youtu.be/Rsz6XRLGq78?si… via YouTube En este video, la Dra. Maria Antonia Vélez analiza los ensayos clínicos de fase III y lo que una persona puede esperar al participar en uno, así como

Ensayos Clínicos 101: Mitos y Preguntas Frecuentes - 2025 Patient Education Ambassadors Program youtu.be/V23MZMKC40o?si… via YouTube En este video, la Dra. Maria Antonia Vélez analiza los mitos comunes sobre los ensayos clínicos y las preguntas más frecuentes sobre la participación en

🎯 EQUAL SPOTLIGHT After losing multiple family members to lung cancer and being diagnosed at 39, Jill Feldman searched for answers and a community. She helped build EGFR Resisters and now fights for equity in lung cancer screening. #EQUALStudy #LungCancer #HealthEquity

Unsolicited career advice: If you find an original thinker with a strong moral compass, do whatever it takes to work with them. Both of those things are incredibly rare standalone, even rarer when together. They are also are traits that cannot be acquired imho.